The Promise of Biosimilars
One of the least well-known but most promising areas of drug research is the creation of generic biologic medicines, or biosimilars....
The Luxottica-Essilor Merger is Looking Rather Strained
In January 2017, the eyewear company Luxottica announced it would acquire Essilor, a large French company that produces ophthalmic lenses...
As CHIP Funding Shortage Looms, States Are Increasingly Concerned
On September 30th, funding for the Children's Health Insurance Program (CHIP), which provides low-cost health coverage to children in...
An Unwanted Sequel: Merger of CVS and Aetna Would Raise Prices and Harm Consumers
There they go again. Yesterday, CVS Health announced it has agreed to build the health insurance company Aetna for $69 billion in a...
